Structural connectivity and response to ketamine therapy in major depression: A preliminary study.

BACKGROUND Ketamine elicits an acute antidepressant effect in patients with major depressive disorder (MDD). Here, we used diffusion imaging to explore whether regional differences in white matter microstructure prior to treatment may predict clinical response 24h following ketamine infusion in 10 MDD patients. METHODS FSL's Tract-Based Spatial Statistics (TBSS) established voxel-level differences in fractional anisotropy (FA) between responders (patients showing >50% improvement in symptoms 24h post-infusion) and non-responders in major white matter pathways. Follow-up regions-of-interest (ROI) analyses examined differences in FA and radial (RD), axial (AD) and mean diffusivity (MD) between responders and non-responders and 15 age- and sex-matched controls, with groups compared pairwise. RESULTS Whole brain TBSS (p<0.05, corrected) and confirmatory tract-based regions-of-interest analyses showed larger FA values in the cingulum and forceps minor in responders compared to non-responders; complementary decreases in RD occurred in the cingulum (p<0.05). Only non-responders differed from controls showing decreased FA in the forceps minor, increased RD in the cingulum and forceps minor, and increased MD in the forceps minor (p<0.05). LIMITATIONS Non-responders showed an earlier age of onset and longer current depressive episode than responders. Though these factors did not interact with diffusion metrics, results may be impacted by the limited sample size. CONCLUSIONS Though findings are considered preliminary, significant differences in FA, RD and MD shown in non-responders compared to responders and controls in fronto-limbic and ventral striatal pathways suggest that the structural architecture of specific functional networks mediating emotion may predict ketamine response in MDD.

[1]  Heather L. Urry,et al.  Failure to Regulate: Counterproductive Recruitment of Top-Down Prefrontal-Subcortical Circuitry in Major Depression , 2007, The Journal of Neuroscience.

[2]  Scott T. Grafton,et al.  Automated image registration: I. General methods and intrasubject, intramodality validation. , 1998, Journal of computer assisted tomography.

[3]  M. Rushworth,et al.  Controlling Human Striatal Cognitive Function via the Frontal Cortex , 2012, The Journal of Neuroscience.

[4]  J. Sato,et al.  Hippocampal volume and the rapid antidepressant effect of ketamine , 2015, Journal of psychopharmacology.

[5]  Clare E. Mackay,et al.  A Systematic Review of Diffusion Tensor Imaging Studies in Affective Disorders , 2009, Biological Psychiatry.

[6]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[7]  B. Vogt.  Pain and emotion interactions in subregions of the cingulate gyrus , 2005, Nature Reviews Neuroscience.

[8]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[9]  Carlos A. Zarate,et al.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders , 2008, Nature Reviews Drug Discovery.

[10]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[11]  Richard Coppola,et al.  Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine , 2009, Biological Psychiatry.

[12]  J. P. Hamilton,et al.  Neuroimaging and Depression , 2008 .

[13]  Luis Concha,et al.  Diffusion tensor imaging of time-dependent axonal and myelin degradation after corpus callosotomy in epilepsy patients , 2006, NeuroImage.

[14]  P. Basser,et al.  Estimation of the effective self-diffusion tensor from the NMR spin echo. , 1994, Journal of magnetic resonance. Series B.

[15]  Thomas Frodl,et al.  Meta-analysis of diffusion tensor imaging studies shows altered fractional anisotropy occurring in distinct brain areas in association with depression , 2011, Biology of Mood & Anxiety Disorders.

[16]  D. Luckenbaugh,et al.  Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression. , 2015, Journal of affective disorders.

[17]  M. Phillips,et al.  Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder , 2015, Translational Psychiatry.

[18]  Shantanu H. Joshi,et al.  Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression , 2014, Translational Psychiatry.

[19]  L. Williams,et al.  Abnormal Structural Networks Characterize Major Depressive Disorder: A Connectome Analysis , 2014, Biological Psychiatry.

[20]  Shu-Wei Sun,et al.  Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.

[21]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[22]  D. Charney,et al.  Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. , 2014, The international journal of neuropsychopharmacology.

[23]  K. Krishnan,et al.  Frontal White Matter Anisotropy and Antidepressant Remission in Late-Life Depression , 2008, PloS one.

[24]  L. Williams,et al.  Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder , 2014, British Journal of Psychiatry.

[25]  Peter Herscovitch,et al.  Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study , 2013, Biological Psychiatry.

[26]  Jordan Grafman,et al.  The functional neuroanatomy of depression: Distinct roles for ventromedial and dorsolateral prefrontal cortex , 2009, Behavioural Brain Research.

[27]  J. Price,et al.  Neural circuits underlying the pathophysiology of mood disorders , 2012, Trends in Cognitive Sciences.

[28]  D. Luckenbaugh,et al.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. , 2014, Annual review of pharmacology and toxicology.

[29]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[30]  K. Luan Phan,et al.  Functional Neuroanatomy of Emotion: A Meta-Analysis of Emotion Activation Studies in PET and fMRI , 2002, NeuroImage.

[31]  C. Altar,et al.  A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013. , 2014, Psychiatric services.

[32]  J. P. Hamilton,et al.  Neural systems approaches to understanding major depressive disorder: An intrinsic functional organization perspective , 2013, Neurobiology of Disease.

[33]  M. Trivedi,et al.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. , 2015, The American journal of psychiatry.

[34]  S. Wakana,et al.  Fiber tract-based atlas of human white matter anatomy. , 2004, Radiology.

[35]  Mark W. Woolrich,et al.  Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.

[36]  Tom Holroyd,et al.  Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine , 2010, Neuropsychopharmacology.

[37]  D. Luckenbaugh,et al.  Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study , 2012, Neuropsychopharmacology.